Signaturefd, LLC Astrazeneca PLC Transaction History

Signaturefd, LLC

$5.8 Billion
Q3 2025

A detailed history of Signaturefd, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Signaturefd, LLC holds 63,936 shares of AZN stock, worth $5.72 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

63,936

Previous 60,233 6.15%

Holding current value

$5.72 Million

Previous $4.21 Million 16.54%

% of portfolio

0.08%

Previous 0.08%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$68.72 - $82.11 $254,470 - $304,053	3,703 Added 6.15%	63,936 $4.91 Million
Q2 2025 Jul 16, 2025	SELL	$64.87 - $75.0 $216,017 - $249,750	-3,330 Reduced 5.24%	60,233 $4.21 Million
Q1 2025 May 01, 2025	BUY	$65.37 - $77.96 $223,369 - $266,389	3,417 Added 5.68%	63,563 $4.67 Million
Q4 2024 Feb 10, 2025	BUY	$63.2 - $79.58 $57,069 - $71,860	903 Added 1.52%	60,146 $3.94 Million
Q3 2024 Oct 21, 2024	BUY	$76.67 - $87.62 $156,790 - $179,182	2,045 Added 3.58%	59,243 $4.62 Million

Q2 2024 Jul 29, 2024	BUY	$66.81 - $80.83 $477,090 - $577,207	7,141 Added 14.27%	57,198 $4.46 Million
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $192,549 - $219,493	3,155 Added 6.73%	50,057 $3.39 Million
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $31,378 - $35,124	-507 Reduced 1.07%	46,902 $3.16 Million
Q3 2023 Nov 03, 2023	BUY	$64.85 - $71.7 $180,736 - $199,827	2,787 Added 6.25%	47,409 $3.21 Million
Q2 2023 Aug 01, 2023	BUY	$69.91 - $75.81 $157,577 - $170,875	2,254 Added 5.32%	44,622 $3.19 Million
Q1 2023 Apr 28, 2023	BUY	$63.15 - $71.6 $97,251 - $110,263	1,540 Added 3.77%	42,368 $2.94 Million
Q4 2022 Jan 27, 2023	BUY	$54.21 - $70.44 $343,257 - $446,026	6,332 Added 18.36%	40,828 $2.77 Million
Q3 2022 Nov 08, 2022	SELL	$53.02 - $135.75 $207,043 - $530,103	-3,905 Reduced 10.17%	34,496 $1.89 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $80,889 - $97,106	1,365 Added 3.69%	38,401 $2.54 Million
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $307,184 - $370,032	5,513 Added 17.49%	37,036 $2.46 Million
Q4 2021 Jan 25, 2022	BUY	$54.02 - $63.83 $87,512 - $103,404	1,620 Added 5.42%	31,523 $1.84 Million
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $240,574 - $263,220	4,330 Added 16.93%	29,903 $1.8 Million
Q2 2021 Jul 26, 2021	BUY	$48.42 - $60.18 $71,177 - $88,464	1,470 Added 6.1%	25,573 $1.53 Million
Q1 2021 Apr 30, 2021	BUY	$47.16 - $54.44 $22,872 - $26,403	485 Added 2.05%	24,103 $1.2 Million
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $770,206 - $921,009	-15,874 Reduced 40.2%	23,618 $1.18 Million
Q3 2020 Nov 03, 2020	BUY	$53.07 - $61.1 $981,635 - $1.13 Million	18,497 Added 88.1%	39,492 $2.16 Million
Q2 2020 Jul 30, 2020	SELL	$43.1 - $55.31 $64,908 - $83,296	-1,506 Reduced 6.69%	20,995 $1.11 Million
Q1 2020 Apr 23, 2020	SELL	$37.79 - $51.33 $391,504 - $531,778	-10,360 Reduced 31.53%	22,501 $1.01 Million
Q4 2019 Feb 05, 2020	BUY	$42.46 - $50.46 $767,804 - $912,468	18,083 Added 122.36%	32,861 $1.64 Million
Q3 2019 Oct 16, 2019	BUY	$40.12 - $45.47 $73,219 - $82,982	1,825 Added 14.09%	14,778 $659,000
Q2 2019 Jul 31, 2019	SELL	$37.28 - $41.68 $53,012 - $59,268	-1,422 Reduced 9.89%	12,953 $535,000
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $43,679 - $49,165	1,185 Added 8.98%	14,375 $546,000
Q3 2018 Nov 15, 2018	BUY	$34.76 - $39.72 $6,604 - $7,546	190 Added 1.46%	13,190 $522,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $46,400 - $49,758	1,343 Added 11.52%	13,000 $456,000
Q1 2018 May 08, 2018	BUY	$32.97 - $36.63 $67,720 - $75,238	2,054 Added 21.39%	11,657 $408,000
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $14,023 - $15,198	437 Added 4.77%	9,603 $333,000
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $51,259 - $60,180	1,770 Added 23.93%	9,166 $311,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,396	7,396 $252,000

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

501M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account